Migraine Science
How Migraine Medications Are Tested
Posted on December 10 2024,
Stay in the Loop on the Latest in Migraine:
1. Testing Immediate Relief Medications (Acute Treatment)
| What's Being Tested | Previous Standards | Current Standards |
|---|---|---|
| How Often Patients Need to Have Migraine Attacks to Join the Study | 1-6 migraine attacks per month | 2-8 migraine attacks per month, <15 headache days |
| How Success is Measured (primary endpoint) |
Whether migraine attack resolved at 2 hours |
Whether pain is completely gone at 2 hours AND most bothersome symptom |
| Additional Success Measures | Just pain relief | • Complete pain relief • Relief from most bothersome symptom • Whether relief lasts for 24-48 hours |
| Side Effect Tracking | Basic tracking | Detailed reporting of all side effects |
2. Testing Preventive Medications
| What's Being Tested | Previous Standards | Current Standards |
|---|---|---|
| Who Can Participate | People with 2-6 migraine attacks monthly | People with up to 15 migraine attacks monthly |
| How Success is Measured (primary endpoint) | Counting fewer attacks | Either: • Fewer migraine attack days per month • At least 50% reduction in migraine days (should be the secondary endpoint, if not the primary) |
3. Special Cases
For People with Chronic Migraine
| What's Important | Details |
|---|---|
| Who Can Participate | People can be included even if they have medication overuse/adaptation headache |
| Success Measures (primary endpoint) | Reduction in number of moderate/severe headache days |
| Additional Benefits (secondary endpoint) | Whether migraine attacks become less frequent overall (conversion to episodic migraine) |
For Children and Adolescents
| What's Important | Details |
|---|---|
| Age Groups | Ages 6-17 allowed to participate |
| Special Requirements | • Must have had migraine attacks for at least 6 months • Parents can help report symptoms • Studies must run year-round (not just during school) |
For Migraine with Visual/Sensory/Speech or Language Symptoms (Aura)
| What's Important | Details |
|---|---|
| Minimum Requirement | At least one migraine with aura monthly |
| Success Measures | • How often auras occur (primary endpoint) • How often headaches follow the aura (secondary endpoint) |
Mon, Jul 20, 26
Migraine Treatment in Pregnancy and Breastfeeding
Migraine hits hardest during the reproductive years. Here is what the latest evidence says about which migraine medications are safe during pregnancy and breastfeeding, from triptans and NSAIDs to topiramate,...
Read MoreMon, Jul 13, 26
Rimegepant for Migraine Prevention: Real-World Evidence
New real-world data on rimegepant for migraine prevention: a 75 mg every-other-day gepant that also treats attacks. What the GEMA study found on response rates, dosing, and why earlier use...
Read MoreMon, Jul 13, 26
Placebo Response in Migraine Trials: What a 126-Study Analysis Found
A new Neurology meta-analysis of 126 acute migraine trials found that about 1 in 9 people reach 2-hour pain freedom on placebo alone, and that placebo response has been rising...
Read More
